Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo

Trial Profile

Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2018

At a glance

  • Drugs Tolperisone (Primary) ; Cyclobenzaprine
  • Indications Muscle hypertonia; Muscle spasticity
  • Focus Therapeutic Use
  • Sponsors Neurana Pharmaceuticals
  • Most Recent Events

    • 24 Oct 2018 Results (n=31) presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 17 Oct 2018 According to a Neurana Pharmaceuticals media release, data from the study will be presented at the American College of Rheumatology's Annual Meeting (ACR/ARHP) 2018.
    • 01 Oct 2018 According to a Neurana Pharmaceuticals media release, data will be presented at the American College of Emergency Physicians (ACEP) 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top